Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2010 July;76(7) > Minerva Anestesiologica 2010 July;76(7):550-3



To subscribe PROMO
Submit an article
Recommend to your librarian





Minerva Anestesiologica 2010 July;76(7):550-3


language: English

Total hepatectomy, recombinant activated factor VII and rescue liver transplantation

Cozzi P. 1, Chiumello D. 1, Tubiolo D. 1, Sicignano A. 1, Brandi G. 1, Bianchi P. 1, Coppola S. 1, Caspani M. L. 1, Rossi G. 2

1 Department of Anesthesia and Intensive Care, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy; 2 Liver Transplant Center, Institute of Experimental Surgery and Transplantation, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Milan, Italy


The aim of this paper was to describe a case of acute liver failure treated with total hepatectomy, recombinant activated factor VII and rescue liver transplantation. We reported our experience with a 51-year-old-woman who developed a massive portal thrombosis after cadaveric liver transplantation for hepatic epithelioid hemangioendothelioma and who then required a total hepatectomy and porto-caval shunt as a bridge procedure while waiting for an urgent new liver transplantation. Subsequently, the patient developed severe hemodynamic instability, massive abdominal and mucosal bleeding and acute renal failure that were managed with infusion of high doses of inotropes, red blood cells and fresh frozen plasma as well as continuous veno-venous hemofiltration. Due to persistent, uncontrolled bleeding, we considered the off-label use of rFVIIa. This caused a correction of the prothrombin times and allowed for sufficient hemostasis. The patient received a new cadaveric liver that was reperfused 38 hours after the first graft was removed. The transplanted liver showed immediate recovery, the hemodynamics ameliorated and the patient was fully awake at day five. In the case of an anhepatic phase complicated by severe bleeding that is unresponsiveness to several transfusions, a single administration of rFVIIa should be considered as a rescue therapy to control massive bleeding.

top of page